Synapse

← Sanjay Kaul

Papers by Sanjay Kaul

Page 1 · newest first

  1. LAAC for Atrial FibrillationJournal of the American College of Cardiology · 2026
  2. ACCF 2012 Expert Consensus Document on Practical Clinical Considerations in the Interpretation of Troponin ElevationsJournal of the American College of Cardiology · 2012
  3. Reappraisal of Evidentiary Support for Transcatheter Aortic Valve Implantation for Low-Risk Aortic StenosisJournal of the American College of Cardiology · 2025
  4. Emerging Longer-Term Evidence on Transcatheter Aortic Valve Implantation for Severe Aortic Stenosis in Low-Risk Patients: A Call for CautionThe Annals of Thoracic Surgery · 2026
  5. Cross the Road EarlyJournal of the American College of Cardiology · 2026
  6. What makes a meta-analysis believable?The Lancet · 2026
  7. Funding Source and the Online and Academic Impact of Cardiovascular TrialsJournal of the American College of Cardiology · 2026
  8. The 2025 Guideline Update Endorses Ticagrelor Monotherapy After ≥1 Month of DAPT Post-PCI in Patients With ACSJournal of the American College of Cardiology · 2025
  9. 2012 ACCF/AATS/SCAI/STS Expert Consensus Document on Transcatheter Aortic Valve ReplacementJournal of the American College of Cardiology · 2012
  10. Prior convictionsJournal of the American College of Cardiology · 2004
  11. ACCF/AHA New Insights Into the Methodology of Performance MeasurementJournal of the American College of Cardiology · 2010
  12. ACCF/ACG/AHA 2008 Expert Consensus Document on Reducing the Gastrointestinal Risks of Antiplatelet Therapy and NSAID UseJournal of the American College of Cardiology · 2008
  13. ACC 2015 Core Cardiovascular Training Statement (COCATS 4) (Revision of COCATS 3)Journal of the American College of Cardiology · 2015
  14. ACCF/AHA Clopidogrel Clinical Alert: Approaches to the FDA “Boxed Warning”Journal of the American College of Cardiology · 2010
  15. 2017 ACC Expert Consensus Decision Pathway for Transcatheter Aortic Valve Replacement in the Management of Adults With Aortic StenosisJournal of the American College of Cardiology · 2017
  16. Non-inferiority study design: lessons to be learned from cardiovascular trialsEuropean Heart Journal · 2012
  17. Methodological Appraisal of Ongoing Trial of Transcatheter Aortic Valve Implantation Versus Surgical Aortic Valve Replacement in Younger Patients: From Incentives to Guideline-Informing EvidenceEuropean Journal of Cardio-Thoracic Surgery · 2025
  18. Time-to-event analysis of the long-term outcome in trials comparing transcatheter and surgical aortic valve implantation: A meta-analysis.International Journal of Cardiology · 2025
  19. Bayesian Analytical Methods in Cardiovascular Clinical Trials: Why, When, and HowCanadian Journal of Cardiology · 2024
  20. Same evidence different recommendations: a methodological assessment of transatlantic guidelines for the management of valvular heart diseaseEuropean Journal of Cardio-Thoracic Surgery · 2024
  21. Impact of Finerenone-Induced Albuminuria Reduction on Chronic Kidney Disease Outcomes in Type 2 DiabetesAnnals of Internal Medicine · 2023
  22. Safety and Efficacy of Empagliflozin and Diuretic Use in Patients with Heart Failure and Preserved Ejection FractionJAMA Cardiology · 2023
  23. Risk of Bias in Randomized Clinical Trials Comparing Transcatheter and Surgical Aortic Valve ReplacementJAMA Network Open · 2023
  24. Effects of Empagliflozin in Women and Men With Heart Failure and Preserved Ejection FractionCirculation · 2022
  25. Five-year outcomes in trials comparing transcatheter aortic valve implantation versus surgical aortic valve replacement: a pooled meta-analysis of reconstructed time-to-event dataEuropean Journal of Cardio-Thoracic Surgery · 2021
  26. Recommendations for Statistical Reporting in Cardiovascular Medicine: A Special Report From the American Heart AssociationCirculation · 2021
  27. Benefit–Risk Tradeoffs in Assessment of New Drugs and DevicesCirculation · 2020
  28. Lessons Learnt from Recent Trials in Ischemic Heart DiseaseThrombosis and Haemostasis · 2020
  29. Cardiovascular and Renal Outcomes with Empagliflozin in Heart FailureNew England Journal of Medicine · 2020
  30. Non-inferiority trials using a surrogate marker as the primary endpoint: An increasing phenotype in cardiovascular trialsClinical Trials · 2020
  31. Heart Failure End Points in Cardiovascular Outcome Trials of Sodium Glucose Cotransporter 2 Inhibitors in Patients With Type 2 Diabetes MellitusCirculation · 2019
  32. Noninferiority Designed Cardiovascular Trials in Highest-Impact JournalsCirculation · 2019
  33. Impact of High Volume Energy Drink Consumption on Electrocardiographic and Blood Pressure Parameters: A Randomized TrialSHILAP Revista de lepidopterología · 2019
  34. Empagliflozin Reduces the Risk of a Broad Spectrum of Heart Failure Outcomes Regardless of Heart Failure Status at BaselineENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) · 2019
  35. Cardiovascular Outcomes Trials in Type 2 Diabetes: Where Do We Go From Here? Reflections From aDiabetes CareEditors’ Expert ForumDiabetes Care · 2017
  36. Mitigating Cardiovascular Risk in Type 2 Diabetes With Antidiabetes Drugs: A Review of Principal Cardiovascular Outcome Results of EMPA-REG OUTCOME, LEADER, and SUSTAIN-6 TrialsDiabetes Care · 2017
  37. Enhancing Insights into Pulmonary Vascular Disease Through a Precision Medicine Approach. A Joint NHLBI–Cardiovascular Medical Research and Education Fund Workshop ReportAmerican Journal of Respiratory and Critical Care Medicine · 2017
  38. A Tale of Two Trials: Reconciling Differences in Results by Exploring Heterogeneous Treatment EffectsAnnals of Internal Medicine · 2017
  39. Dietary Intervention for Overweight and Obese Adults: Comparison of Low-Carbohydrate and Low-Fat Diets. A Meta-AnalysisSHILAP Revista de lepidopterología · 2015
  40. Moderated ePoster Session 2ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) · 2014
  41. Evaluation of postsurgical clinical outcomes with/without removal of pocket epithelium: A split mouth randomized trialJournal of Indian Society of Periodontology · 2014
  42. The Cardiovascular Safety of Diabetes Drugs — Insights from the Rosiglitazone ExperienceNew England Journal of Medicine · 2013
  43. The rationale for Heart Team decision-making for patients with stable, complex coronary artery diseaseEuropean Heart Journal · 2013
  44. 2012 ACCF/AATS/SCAI/STS expert consensus document on transcatheter aortic valve replacementJournal of Thoracic and Cardiovascular Surgery · 2012
  45. 2012 American college of cardiology foundation/society for cardiovascular angiography and interventions expert consensus document on cardiac catheterization laboratory standards update: American college of cardiology foundation task force on expert consensus documents society of thoracic surgeons society for vascular medicineCatheterization and Cardiovascular Interventions · 2012
  46. The Role of Platelet Reactivity and Genotype Testing in the Prevention of Atherothrombotic Cardiovascular Events Remains UnprovenCirculation · 2012
  47. Fibrates in the Treatment of Dyslipidemias — Time for a ReassessmentNew England Journal of Medicine · 2011
  48. Standardized Bleeding Definitions for Cardiovascular Clinical TrialsCirculation · 2011
  49. Gone Fishing!: On the “Real-World” Accuracy of Computed Tomographic Coronary AngiographyArchives of Internal Medicine · 2011
  50. Dose-Dependent Modulation of Tissue Factor Protein and Procoagulant Activity in Human Monocyte-Derived Macrophages by Oxidized Low Density LipoproteinJournal of Atherosclerosis and Thrombosis · 2011